Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death

Korea began its use of effective therapies for idiopathic pulmonary arterial hypertension (IPAH) early in 2000. Idiopathic hypertension has no apparent cause. Yet there have been very few studies assessing…

Continue Reading Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death
An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
Source: https://pixabay.com/en/thumb-up-like-sign-hand-ok-good-441938/

An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma

Maria’s message is: “when in doubt, get a biopsy." Ten years ago, Maria Sylvia noticed a vertical streak on her thumbnail that at the time she thought was “cool." She…

Continue Reading An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
Rheumatoid arthritis. Source: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA

In the past, certain research has suggested a relationship between the use of therapies like TNF inhibitors, tocilizumab, and tofacitinib, and a heightened risk of Alzheimer’s disease (AD) or dementia.…

Continue Reading TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
International Fibrodysplasia Ossificans Progressiva Awareness Day is on April 23: Spreading Rare Disease Awareness
source: pixabay.com

International Fibrodysplasia Ossificans Progressiva Awareness Day is on April 23: Spreading Rare Disease Awareness

International Fibrodysplasia Ossificans Progressiva (FOP) Awareness Day is recognized each year on April 23rd. This is a time for spreading awareness about this rare disorder among both the general public…

Continue Reading International Fibrodysplasia Ossificans Progressiva Awareness Day is on April 23: Spreading Rare Disease Awareness
Update: Phase 3 Data Published on Ganaxalone for CDD
https://pixabay.com/en/books-stack-reading-read-education-933333/

Update: Phase 3 Data Published on Ganaxalone for CDD

According to a recent article in Businesswire, The Lancet has published data from the third phase of the Marigold trial. This clinical trial evaluated ganaxalone - marketed as ZTALMY - as a…

Continue Reading Update: Phase 3 Data Published on Ganaxalone for CDD
Can Music Therapy Relieve SCD Pain?
https://pixabay.com/en/guitar-music-man-play-strum-chord-869217/

Can Music Therapy Relieve SCD Pain?

Many patients with sickle cell disease (SCD) experience “pain crises,” or periodic episodes of extreme pain. These pain crises occur when sickle-shaped red blood cells block the flow of blood…

Continue Reading Can Music Therapy Relieve SCD Pain?
Donidalorsen Reduces HAE Attacks, Study Shows
Hand swollen during hereditary angioedema attack. Sourced from Wikimedia Commons

Donidalorsen Reduces HAE Attacks, Study Shows

In patients with hereditary angioedema (HAE), the C1-inhibitor blood protein does not function properly, allowing bradykinin peptides to build up in the body. These then cause inflammation and fluid leakage;…

Continue Reading Donidalorsen Reduces HAE Attacks, Study Shows
A New Care Center for Von Hippel-Lindau Disease Has Been Named by the VHL Alliance
https://pixabay.com/en/chicago-usa-america-united-states-690364/

A New Care Center for Von Hippel-Lindau Disease Has Been Named by the VHL Alliance

The VHL Alliance has just recognized Loyola Medicine as a new VHL Clinical Care Center. Von Hippel-Lindau (VHL) disease patients require multidisciplinary care for their complex and rare condition, and…

Continue Reading A New Care Center for Von Hippel-Lindau Disease Has Been Named by the VHL Alliance